Prognostic features and predictive model for mixed invasive ductal and lobular breast carcinoma in early-stage patients
Yongxin Li,
No information about this author
Yinyin Ye,
No information about this author
Xuewei Tao
No information about this author
et al.
Clinical Breast Cancer,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 1, 2025
Language: Английский
Non-invasive prediction of DCE-MRI radiomics model on CCR5 in breast cancer based on a machine learning algorithm
Qingfeng Li,
No information about this author
W. Li,
No information about this author
J Wang
No information about this author
et al.
Cancer Biomarkers,
Journal Year:
2025,
Volume and Issue:
42(5)
Published: May 1, 2025
Background
Non-invasive
methods
with
universal
prognostic
guidance
for
detecting
breast
cancer
(BC)
survival
biomarkers
need
to
be
further
explored.
Objective
This
study
aimed
investigate
C-C
motif
chemokine
receptor
type
5
(CCR5)
prognosis
value
in
BC
and
develop
a
radiomics
model
noninvasive
prediction
of
CCR5
expression
BC.
Methods
A
total
840
cases
genomic
information
were
included
divided
into
high-
low-expression
groups
clinical
characteristic
differences
exploration.
Bioinformatics
analysis
including
Kaplan-Meier
(KM)
analysis,
Cox
regression,
immunoinfiltration
tumor
mutation
load
(TMB)
performed.
For
development,
98
dynamic
contrast-enhancement
magnetic
resonance
imaging
(DCE-MRI)
scans
used.
Radiomics
features
extracted
using
Pyradiomics
filtered
by
maximum-relevance
minimum-redundancy
(mRMR)
recursive
feature
elimination
(REF)
algorithms.
Support
vector
machine
(SVM)
logistic
regression
(LR)
models
developed
predict
expression,
the
score
(Rad_score)
representing
predicted
probability
expression.
The
models’
performance
was
compared
Delong
test,
superior
area
under
curve
(AUC)
values
selected
analyze
correlation
between
Rad_score,
immune
genes.
Results
high-expression
group
exhibited
better
overall
(OS)
(p
<
0.01).
Six
development.
AUCs
SVM
predicting
0.753
0.748
training
validation
sets,
respectively,
while
LR
0.763
0.762.
Calibration
curves
decision
(DCA)
validated
calibration
utility.
SVM_Rad_score
showed
strong
association
immune-related
Conclusions
DCE-MRI
presents
novel,
non-invasive
tool
provides
valuable
insights
inform
decision-making.
Language: Английский
Spatial transcriptomics: a new frontier in accurate localization of breast cancer diagnosis and treatment
Yang Zhang,
No information about this author
Shuhua Gong,
No information about this author
Xiaofei Liu
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Oct. 8, 2024
Breast
cancer
is
one
of
the
most
prevalent
cancers
in
women
globally.
Its
treatment
and
prognosis
are
significantly
influenced
by
tumor
microenvironment
heterogeneity.
Precision
therapy
enhances
efficacy,
reduces
unwanted
side
effects,
maximizes
patients’
survival
duration
while
improving
their
quality
life.
Spatial
transcriptomics
significant
importance
for
precise
breast
cancer,
playing
a
critical
role
revealing
internal
structural
differences
tumors
composition
microenvironment.
It
offers
novel
perspective
studying
spatial
structure
cell
interactions
within
tumors,
facilitating
more
effective
personalized
treatments
cancer.
This
article
will
summarize
latest
findings
diagnosis
from
transcriptomics,
focusing
on
revelation
microenvironment,
identification
new
therapeutic
targets,
enhancement
disease
diagnostic
accuracy,
comprehension
progression
metastasis,
assessment
drug
responses,
creation
high-resolution
maps
cells,
representation
heterogeneity,
support
clinical
decision-making,
particularly
elucidating
immunotherapy
correlation
with
outcomes.
Language: Английский
Glutamate Transport Proteins and Metabolic Enzymes are Poor Prognostic Factors in Invasive Lobular Carcinoma
Todd Young,
No information about this author
Shaymaa Bahnassy,
No information about this author
Theresa C. Abalum
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 29, 2024
Invasive
Lobular
Carcinoma
(ILC)
is
a
subtype
of
breast
cancer
characterized
by
distinct
biological
features,
and
limited
glucose
uptake
coupled
with
increased
reliance
on
amino
acid
lipid
metabolism.
Our
prior
studies
highlight
the
importance
glutamate
as
key
regulator
ILC
tumor
growth
therapeutic
response.
Here
we
examine
expression
four
proteins
involved
in
transport
metabolism
-
SLC3A2,
SLC7A11,
GPX4,
GLUD1/2
racially
diverse
cohort
72
estrogen
receptor-positive
(ER+)
50
ER+
invasive
ductal
carcinoma,
no
special
type
(IDC/NST)
patients
primary
disease.
All
are
associated
size
ILC,
but
not
IDC/NST,
SLC3A2
also
specifically
linked
to
shorter
overall
survival
presence
comorbidities
ILC.
Notably,
ER
most
strongly
stage
Black
women
from
our
TCGA.
We
further
explore
effects
GLUD1
inhibition
endocrine
therapy-resistant
cells
using
small-molecule
inhibitor
R162,
which
reduces
protein
levels,
increases
reactive
oxygen
species,
inhibits
oxidative
phosphorylation.
These
findings
potentially
important
role
for
particularly
women,
position
several
these
glutamate-handling
potential
targets
intervention
Language: Английский